SCCM Resource Library-The Effect of High-Flow Nasal Cannula on Hospital Length of Stay in Pediatric Asthma

The Effect of High-Flow Nasal Cannula on Hospital Length of Stay in Pediatric Asthma

Video Transcription

Video Summary

The study discussed in the video focused on the use of high-flow nasal cannula (HFNC) in pediatric asthma patients and its impact on hospital length of stay. HFNC is commonly used in the ICU and has various proposed mechanisms of action, but there is debate regarding its effectiveness in delivering nebulized medications. The study, which was conducted retrospectively using a matched cohort design, found that pediatric asthma patients treated with HFNC had a longer hospital stay compared to those treated with other methods. However, further studies are needed to validate these findings. The research team is also working on obtaining additional datasets and variables to enhance their analysis.

Asset Subtitle

Pediatrics, Pulmonary, 2023

Asset Caption

Type: star research | Star Research Presentations: Pulmonary, Adult and Pediatric (SessionID 30003)

Meta Tag

Content Type Presentation

Knowledge Area Pediatrics

Knowledge Area Pulmonary

Membership Level Professional

Membership Level Select

Tag Pediatrics

Tag Asthma

Year 2023

Keywords

high-flow nasal cannula

pediatric asthma patients

hospital length of stay

ICU

nebulized medications

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.